Key result
The M3 muscarinic receptor offers potential cardioprotection against heart injury via microRNA regulation.
This review highlights the ubiquitous pathophysiological roles of the M3 muscarinic receptor in cardiac diseases and its potential as a therapeutic target.
Answers are grounded in this paper and cite their sources.
Should not change clinical practice for cardiac injury; hypothesis-generating for M3 receptor modulation in cardioprotection.
Cardiac diseases remain the leading cause of morbidity and mortality worldwide. Heart functions are regulated by autonomic nervous systems through their transmitters and modulators, binding to cell surface receptors. Among them, the cardiac M(3) muscarinic acetylcholine receptor (M(3)-mAChR) has been studied for more than 2 decades since its first discovery in mammalian heart in 1990s. The location and pathophysiological role of M(3)-mAChR in the cardiovascular system have been extensively studied and many pathways involved have been uncovered. Gain- and loss-of-function studies have revealed the ubiquitous roles of M(3)-mAChR in physiological and pathological conditions. Recently, many new findings have been uncovered about the relationship between M(3)-mAChR and cardiac diseases, including cardiac ischemia, pathological cardiac hypertrophy, cardiac arrhythmias, cardiac conduction and heart failure. Furthermore, the novel potential cardioprotective role of M(3)-mAChR against heart injury by regulation of microRNAs (miRNAs) has been revealed in the most updated research. In this review, the current new findings on the role of M(3)-mAChR in heart diseases are updated, the downstream signaling pathways are summarized, perspectives and challenges of M(3)-mAChR as therapeutic targets are discussed.
No takes yet. Share an insight, caveat, or question.
Hang et al. (2013) conducted a review in Cardiac diseases. M3 muscarinic acetylcholine receptor (M3-mAChR) was evaluated. The M3 muscarinic acetylcholine receptor plays a ubiquitous role in physiological and pathological cardiac conditions, with potential cardioprotective effects against heart injury via microRNA regulation.
Synapse has enriched 10 related papers. Consider them for comparative context: